Journal profile · MEDICINE, GENERAL & INTERNAL
Precision and Future Medicine
ISSN 2508-7940 · eISSN 2508-7959 · Sungkyunkwan University School of Medi · Korea, Republic of
Precision and Future Medicine: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.5 (journal website); diamond open access (no APC); no APC; median 48 days to acceptance (35 articles, last 24 months); 21 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
Precision and Future Medicine is published by Sungkyunkwan University School of Medi and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cerebrovascular and Carotid Artery Diseases, Gastric Cancer Management and Outcomes and Acute Ischemic Stroke Management, together about 23.4% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
The aims of the Precision and Future Medicine (P&FM) are to convey new messages regarding general medicine to the global community and to encourage and expedite the publication of medical discoveries, innovations, and new concepts in medicine for our beneficiaries. Thus, the journal is distinct from ordinary medical journals as it accepts and publishes new and innovative diagnostic and therapeutic information with greater priority over conventional clinical trial results. We have a particular interest in new discoveries that are readily applicable to patients (such as omics-driven patient care), translational drug discoveries (including preclinical experiments or stem cells), novel diagnostic methods, and medical devices for healthcare in the field of medicine (i.e. cancer, neurologic disease, cardiovascular disease, hereditary disease, infectious disease, degenerative disease, geriatric medicine, gastroenterology, endocrinology, etc.) The journal will consider submissions in areas including, but not limited to, the following: clinical papers, translational, genomic, therapeutic, and biotechnological research papers. The journal also welcomes laboratory and animal studies on new drugs and novel medical devices and those that elucidate targetable mechanisms of human diseases. These aims and scope will be executed through various types of publications—Original Articles, Reviews, Case Reports, Opinions, and Letters to the Editor. The P&FM will be published four times per year: March 31st, June 30th, September 30th, and December 31st.
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, GENERAL & INTERNAL
Editor-in-chief Hong JinPublisher website
Editorial board by country: 1 in mainland China (about 3%); most named South Korea 26, United States 5, Mainland China 1, Hong Kong, China 1, Taiwan, China 1 (40 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cerebrovascular and Carotid Artery DiseasesMedicine8.6%
- Gastric Cancer Management and OutcomesMedicine7.8%
- Acute Ischemic Stroke ManagementMedicine7%
- Prostate Cancer Diagnosis and TreatmentMedicine4.7%
- Genetic Associations and EpidemiologyBiochemistry, Genetics and Molecular Biology4.7%
- Radiomics and Machine Learning in Medical ImagingMedicine4.7%
- Lung Cancer Diagnosis and TreatmentMedicine3.9%
- Liver Disease Diagnosis and TreatmentMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, General & Internal | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, General & Internal | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 0.5Publisher website ·
- h-index
- 15OpenAlex ·
- i10-index
- 24OpenAlex ·
- 2-year mean citedness
- 0.66OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 20LetPub ·
Articles by year OpenAlex count · 207 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 11 | 11 | 0 |
| 2025 | 21 | 21 | 20 |
| 2024 | 21 | 21 | 15 |
| 2023 | 20 | 20 | 37 |
| 2022 | 19 | 19 | 464 |
| 2021 | 29 | 29 | 80 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
48 daysMedian, submission to acceptance · P25–P75 28 days – 73 days
- Acceptance to online
- median 29 days (35 articles)
- Submission to online
- median 77 days
- Sample
- 35 articles with submission and acceptance dates (42 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC | |
| LetPub | No APC | No | — | |
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Cover letter
- Required
Article types accepted9, with length limits
- case reports, tables, figure legends, and figures. Case reports are limited to 1,500 words (excluding the abstract, references, tables, and legends),main text ≤ 1,500 words
- conference paper7. Rice AS, Brooks JW. Canabinoids and pain. In: Dostorovsky JO, Carr DB, editors. Proceedings of the 10th World Congress on Pain; 2002 Aug 17-22; San Diego, CA…Length not stated
- editorialered to be of interest to P&FM readers. Editorials should not exceed 1,000 words, excluding references, tables, and figures. References shoumain text ≤ 1,000 words
- letterreply. No abstraction is required. The letter should be 1,000 words or less (excluding references and figure legends) with a mamain text ≤ 1,000 words
- letter to the editorLetters to the editor may be in response to a published article or a short, free-standing piece expressing an opinion. If the letters to the editor is in respon…Length not stated
- original articleOriginal ArticleLength not stated
- research methodResearch methods are original work reporting on methodological issues. They present methodological approaches, modifications of existing methods, or discussions…Length not stated
- research method analysisResearch Method AnalysisLength not stated
- reviewReviewLength not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, License & copyright, Open access, Peer review, Plagiarism, Self-archiving, Trial registration / reporting guidelines
- Authorship 1. Authorship and Author’s Responsibility
Authorship credit should be based on (1) the substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; (2) the drafting of the article or its critical revision for important intellectual content; (3) the final approval of the version to be published; and (4) the agreement to be accountable for all aspects of the work by ensuring that questions…
Source ↗Publisher website ·- Conflicts of interest 4. Conflict of Interest Statement
The corresponding author must inform the editor of any potential conflicts of interest that could influence the authors’ interpretation of the data. Examples of potential conflicts of interest are financial support from or connections to pharmaceutical companies, political pressure from interest groups, and academically related issues. In particular, all sources of funding applicable to the study …
Source ↗Publisher website ·- License & copyright 1. Copyright
Copyright to all the published material is owned by Sungkyunkwan University School of Medicine. The authors should agree to the copyright transfer during the submission process. The corresponding author is responsible for submitting the copyright transfer agreement to the Publisher. 2. Open Access Policy P&FM is an open access journal. Articles are distributed under the terms of the Creative Commo…
Source ↗Publisher website ·- Open access COPYRIGHTS, OPEN ACCESS POLICY
Open access under CC BY-NC 4.0 Model summary
1. Copyright Copyright to all the published material is owned by Sungkyunkwan University School of Medicine. The authors should agree to the copyright transfer during the submission process. The corresponding author is responsible for submitting the copyright transfer agreement to the Publisher. 2. Open Access Policy P&FM is an open access journal. Articles are distributed under the terms of the C…
Source ↗Publisher website ·- Peer review SUBMISSION & PEER REVIEW PROCESS
1. Submission •Online submission: All manuscripts should be submitted online via the journal’s website (https://mc04.manuscriptcentral.com/pfm/) by the corresponding author. Once you have logged into your account, the on-line system will lead you through the submission process in a step-by-step orderly process. Submission instructions are available at the website. All articles submitted to the jou…
Source ↗Publisher website ·- Plagiarism 2. Originality, Plagiarism, and Duplicate Publication
Plagiarism screening via Crossref Similarity Check Model summary
Submitted manuscripts must not have been previously published or be under consideration for publication elsewhere. No part of the accepted manuscript should be duplicated in any other scientific journal without the permission of the Editorial Board. Submitted manuscripts are screened for possible plagiarism or duplicate publication by Crossref Similarity Check (https://www.crossref.org/get-started…
Source ↗Publisher website ·- Self-archiving
Self-archiving: post-prints and publisher's version allowed, pre-prints not Model summary
According to Sherpa/Romeo (http://www.sherpa.ac.uk) Authors cannot archive pre-prints (i.e., pre-refereeing) but archive post-prints (i.e., final draft post-refereeing) and publisher’s version/PDF.
Source ↗Publisher website ·- Trial registration / reporting guidelines 2. Reporting Guidelines for Specific Study Designs
Research reports frequently omit important information. As such, reporting guidelines have been developed for a number of study designs, and some journals may ask authors to follow them. Authors are encouraged to also consult the reporting guidelines relevant to their specific research design. A good source for reporting guidelines is the EQUATOR Network (http://www.equator-network.org/home/) and …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Sungkyunkwan University School of Medi
- Country or region
- Korea, Republic of
- Language
- English
- ISSN
- 2508-7940
- Electronic ISSN
- 2508-7959
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Precision and Future Medicine
What CAS zone is Precision and Future Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Precision and Future Medicine is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, General & Internal. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Precision and Future Medicine?
The journal's website gives an impact factor of 0.5; this is the journal's own figure, as LetPub lists none for it; h-index 15.
How long does peer review take at Precision and Future Medicine?
Based on the dates recorded on 35 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 48 days (interquartile range 28–73 days); authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Precision and Future Medicine based?
Of the 40 board members whose country the journal's board page names, 1 (about 3%) are in mainland China; the countries named most often are South Korea (26), United States (5) and Mainland China (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Precision and Future Medicine?
According to LetPub and DOAJ records, Precision and Future Medicine is indexed in ESCI and DOAJ.
Is Precision and Future Medicine open access, and what is the APC?
Precision and Future Medicine is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .